Palvella Therapeutics (PVLA) Receivables - Other: 2019-2024
Historic Receivables - Other for Palvella Therapeutics (PVLA) over the last 1 years, with Sep 2024 value amounting to $506,000.
- Palvella Therapeutics' Receivables - Other was N/A to $506,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $506,000, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2023, which is 34.16% down from last year.
- Palvella Therapeutics' Receivables - Other amounted to $506,000 in Q3 2024, which was down 83.40% from $3.0 million recorded in Q2 2024.
- Palvella Therapeutics' Receivables - Other's 5-year high stood at $4.8 million during Q4 2022, with a 5-year trough of $506,000 in Q3 2024.
- For the 3-year period, Palvella Therapeutics' Receivables - Other averaged around $2.9 million, with its median value being $3.1 million (2024).
- Data for Palvella Therapeutics' Receivables - Other shows a maximum YoY tumbled of 34.16% (in 2023) over the last 5 years.
- Quarterly analysis of 3 years shows Palvella Therapeutics' Receivables - Other stood at $4.8 million in 2022, then slumped by 34.16% to $3.1 million in 2023, then reached $506,000 in 2024.
- Its Receivables - Other was $506,000 in Q3 2024, compared to $3.0 million in Q2 2024 and $3.1 million in Q1 2024.